Faron Pharmaceuticals OY (FARN) NPV
7.50p
(3.49%)
- Add to watchlist
- Create an alert
- This stock can be held in a
7.50p
(3.49%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
7.50p
(3.49%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
210.00p
215.00p
316.50p
£89.83 million
215.00p
205.00p
54.00p
n/a
5.00p (2.38%) Previous:
5.00p
28,326
n/a
5,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2018 | 31/12/2017 |
|---|---|---|
| Revenue (€m) | 0.02 | n/a |
| Profit before tax (€m) | (20.08) | (21.06) |
| Adjusted EPS (¢): | (64.99) | (75.98) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: Euro
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 1) -
Sell
(0 of 1) -
Neutral
(1 of 1) -
Buy
(0 of 1) -
Strong Buy
(0 of 1)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
Faron Pharma requests arbitration over Traumakine manufacturing deal
30 December 2019 15:39
-
Faron Pharmaceuticals upbeat on new data from 'MATINS' study
11 December 2019 13:42
-
Faron Pharmaceuticals positive on feedback from 'Clevegen' monitoring committee
9 October 2019 14:05
-
Traumakine update
6 February 2020 07:00
-
Ovarian cancer selected as 2nd MATINS trial cohort
27 January 2020 07:00
-
DMC approves colorectal cancer cohort expansion
13 January 2020 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Annual & interim reports
Annual & interim reports are not available for this stock.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.